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Abstract The Near-infrared spectroscopy (NIRS) has not
been adopted as a mainstream monitoring modality in acute
neurosurgical care due to concerns about its reliability and
consistency. However, improvements in NIRS parameter
recovery techniques are now available that may improve
the quantitative accuracy of NIRS for this clinical context.
Therefore, the aim of this study was to compare the abil-
ities of a continuous-wave (CW) NIRS device with a
similarly clinically viable NIRS device utilising a fre-
quency-domain (FD) parameter recovery technique in
detecting changes in cerebral tissue saturation during
stepwise increases of experimentally induced hypoxia.
Nine healthy individuals (6M/3F) underwent a dynamic
end-tidal forced manipulation of their expiratory gases to
induce a stepwise induced hypoxia. The minimum end-
tidal oxygen partial pressure (EtO2) achieved was 40 mm
Hg. Simultaneous neurological and extra-cranial tissue
NIRS reading were obtained during this protocol by both
tested devices. Both devices detected significant changes in
cerebral tissue saturation during the induction of hypoxia
(CW 9.8 ± 2.3 %; FD 7.0 ± 3.4 %; Wilcoxon signed rank
test P\ 0.01 for both devices). No significant difference
was observed between the saturation changes observed by
either device (P = 0.625). An observably greater degree of
noise was noticed in parameters recovered by the FD
device, and both demonstrated equally variable baseline
readings (Coefficient of variance 8.4 and 9.7 % for the CW
and FD devices, respectively) between individuals tested.
No advantageous difference was observed in parameters
recovered from the FD device compared with those
detected by CW.
Keywords Head injury  Cerebral blood flow  Frequency-
domain near-infrared spectroscopy  Continuous-wave
near-infrared spectroscopy
1 Background
Near-infrared spectroscopy (NIRS) represents a brain
monitoring modality with many inherent advantages over
available alternatives, not least its non-invasive nature,
ease of application and minimal inter-observer/operator
variability. Although not yet considered sufficiently accu-
rate or consistent in its observations to be utilised within
the context of brain injury or acute neurosurgical care
[1, 2], the technology is commonly utilised in other clinical
contexts that have potential implications on brain perfusion
(e.g., cardiac surgery).
Since its introduction as a clinically available monitoring
modality, considerable progress has been made in technol-
ogy by which the NIRS parameters are recovered [3, 4], with
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parameter recovery techniques evolving from those depen-
dant solely on continuously emitted light (continuous-wave)
to those incorporating frequency modulation (frequency-
domain) and time of flight data (time-domain). Continuous-
wave (CW) devices rely on specific assumptions within an
algorithmic reconstruction, a modified Beer–Lambert prin-
ciple (Fig. 1), based on the function of wavelength only
regarding light scattering through the tissue medium con-
taining chromophores (light absorbing substances). These
basic principles critically assume that the degree of scatter
within all areas of the field of NIRS acquisition is not only
homogenous but also fixed. These assumptions are critical in
the calculation of the recovered NIRS parameters, as it has
been clearly demonstrated that modification of the recon-
struction algorithm can produce very different results from
identical raw NIRS data [5]. In addition to the reliance on
assumptionsmade on scatter, another critical shortcoming of
the CW is the assumed differential path length (L), which
represents the estimated distance travelled by the light. This
estimate fundamentally limits the accuracy of any interpre-
tation of the output parameters.
One reason for the vast majority of clinical investigations
employing CW-NIRS at the point of patient care is the sig-
nificant cost benefit over more advanced commercially
available methods of NIRS parameter recovery [6]. In order
to improve the validity of CW-NIRS, multiple algorithmic
manipulations have been attempted to accurately resolve
NIRS parameters from a specific depth and therefore isolate
light that has followed a specific path through the biological
tissue. These resolution techniques or spatially resolved
spectroscopy (SRS) have been adopted widely to enhance
the output parameters of multiple CW-NIRS devices, most
notably the Suzuki SRS concept [7] as implemented by
Hamamatsu in their NIRO device. Although by nomeans the
only SRS methodology, it serves as an excellent illustration
of how parameters can be manipulated to improve the depth
resolution of raw data obtained from CW devices.
Briefly, this SRS analytical solution assumes that the
plate of tissue is a semi-infinite space in either direction
and incorporates the horizontal distance between the light
source, the light detector (q) and the attenuation of the light
received at the detector (A). In a NIRS array where a single
source of light arrives at 2 separate detectors (each a
specific distance from the source; e.g., 38 and 42 mm) the
gradient derived from the difference in attenuation arriving
at each detector and the distance between each detector
(dA/dq) is utilised in order to isolate the specific portion of
the light detected that has passed through tissue of the
specified depth (dependant on the source detector separa-
tion (Fig. 2).
Frequency-domain (FD) NIRS is a progression of the
CW concept that measures both light intensity attenuation
and phase shift, since the intensity of the light emitted from
these devices is modulated at a particular frequency.
Specifically, observations regarding the shift in phase allow
derivation of a more tissue specific value (quantification) of
the degree of light scatter; hence the magnitude of this
phenomenon is no longer assumed [8]. Theoretically, this
enhanced technique allows more consistent quantitative
measurements to be derived from biological tissue, par-
ticularly in the case of cerebral NIRS where a critical
resolution of output parameters from a specific depth is
required (Fig. 3).
Both of these techniques rely on a number of assump-
tions, and particularly in the case of CW devices (including
those incorporating SRS parameter processing) this may
contribute to superficial tissue perfusion adversely affect-
ing the accuracy of these devices within the clinical arena
[9]. Currently no clinical investigations exist to our
knowledge quantifying the effect of superficial tissue blood
flow on an FD NIRS device, although studies in healthy
individuals have demonstrated this and made suggestions
as to how to minimise its impact [10]. However even with
its potential quantification of scatter within tissues this
measurement is still ‘en-block’ (not depth specific) and will
therefore be theoretically influenced by superficial tissue
activity.
The focus of this investigation is aimed at clinically
viable devices, i.e., devices that are readily available, cost
Fig. 1 Beer–Lambert concept Fig. 2 Suzuki SRS concept illustrated
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effective, usable by non-specialist staff, and have appro-
priate approval for use by the relevant regulatory bodies.
Within the context of acute clinical care (particularly
traumatic brain injury), any such monitoring tool should be
easily applied and removed with minimal preparation.
Focusing our investigation on devices which meet these
criteria maximises the translatability of any findings.
Absolute changes in arterial partial pressure of oxygen
(PaO2) and haemoglobin (Hb) saturation (SaO2) vary
between individuals due to a variety of factors (e.g.
variable compensatory reserves and baseline). Healthy
individuals undergoing induced hypoxia (e.g. at high
altitude or simulated high altitude) have been shown to
vary in terms of their saturation and blood gas composi-
tion. Lucas et al. [11] demonstrated a PaO2 standard
deviation of between 11 mmHg (9.5 % of total) at sea
level and 3 mmHg (7 % of total) at high altitude
(5050 m) with SaO2 demonstrating a standard deviation
of 0.5 % at sea level and approximately 3 % at altitude. A
similar distribution of variation was demonstrated in
arterial partial pressure of carbon dioxide (PaCO2). We
can infer from this that baseline variability (and standard
deviation) in cerebral saturation at sea level and simulated
altitude as observed by a NIRS device of sufficient
quantitative accuracy to be utilised clinically should be
within a similar order.
2 Aims and study design
In this study we aimed to simulate cerebral tissue hypoxia
(a physiological change pertinent to Traumatic Brain Injury
(TBI) pathology) in order to compare output parameters
recorded simultaneously from clinically viable CW and FD
cerebral NIRS devices. Our primary hypothesis being that
the inherent advantages of a system that utilises frequency
domain parameter recovery will demonstrate greater con-
sistency, and accurate quantitative measurements then one
without this technology.
We will test this by utilising a dynamic end-tidal forcing
(DEF) system to induce stepwise hypoxia in healthy vol-
unteers, looking to see if there are any significant differ-
ences in NIRS parameters observed simultaneously by each
device, and if either NIRS modality measured changes in
cerebral tissue with greater consistency (with individuals
undergoing identical hypoxic insults). It is important to
bear in mind that this investigation was not generally
comparing the fundamental FD and CW parameter recov-
ery techniques, instead we are comparing two clinically
viable ‘point of care devices’ where one has the potential
advantage of FD parameter recovery. There are a variety of
differences within each device that represents a confounder
to addressing that specific question (e.g. source detector
configuration and specific algorithmic considerations).
Each participant was exposed to isocapnic hypoxia
using the technique of end-tidal forcing, which achieves
accurate control of end-tidal gases by modifying the
composition of inspired air on a breath-by-breath basis.
This technique provides an intuitive model for studying all
brain pathologies involving hypoxic changes. End-tidal
carbon dioxide partial pressure (ETCO2) has been
demonstrated to closely correlate with PaCO2 [12] and
therefore, by fixing the end-tidal partial pressures during
hypoxia we are also maintaining consistent PaO2 and
PaCO2 and removing a confounding influence of ventila-
tion on brain vascular activity. Although expensive and not
widely available, this technique has proven effective in the
research environment and has been used to demonstrate the
significant influence of end-tidal carbon dioxide partial
pressure has on brain blood flow and autoregulation [13]
during functional magnetic resonance (MR) imaging. We
believe that these experimental conditions will narrow the
variability of cerebral physiology driven by respiratory
factors.
3 Methods
3.1 Participants
Healthy Volunteers recruited from within the University of
Birmingham (UK) took part in this study after providing
their informed written consent. The study conformed to the
Declaration of Helsinki and was approved by the Univer-
sity of Birmingham Research Ethics Board (Ref.: ERN_30-
1031). Individuals recruited had no significant prior med-
ical history.
3.2 Design
A prospective healthy volunteer study, conducted under
controlled laboratory conditions.
Fig. 3 Frequency-domain concept
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3.3 Equipment
The NIRO 200NX (Hamamatsu Photonics, Tokyo, Japan)
CW spectrometer measuring at wavelengths of 735, 810,
and 850 nm was used simultaneously with an ISS Oxi-
plexTS (ISS Inc, Champaign IL, USA) FD device mea-
suring at wavelengths of 690 and 830 nm. Both these
devices are portable, point of care devices that are com-
mercially available to healthcare providers, and fulfil our
requirements as clinically viable monitors. Their respective
probes can be applied easily by individuals with minimal
instruction and training. For ease of comparison and clin-
ical translatability, a single output parameter from each
device was selected. The Tissue Oxygen Index (TOI) and
Tissue Hb Saturation were selected as parameters for
comparison from the NIRO 200NX and ISS, respectively.
It was felt that these represent popular clinically observed
parameters, combining data from each Hb chromophore.
Output parameters from each device were extracted at 1 Hz
for the purposes of direct comparison.
To maintain continuous fixed end-tidal gaseous com-
position a custom made dynamic end-tidal forcing (DEF)
device was employed. Gases were delivered and retrieved
via a soft disposable plastic mouth piece via a filter. A nose
peg was also applied to ensure no room air contamination
due to inspiration through the nares.
3.4 Procedure
Individuals underwent a step-wise DEF induced hypoxia in
a supine position on an examination bed tilted upwardly
approximately 25. Simple skin cleansing and application
of a device specific adhesive tape (in the case of the CW
device only) was all that was undertaken in terms of sur-
face preparation. Once the devices were in place, an elastic
crepe bandage was then applied over the probes along with
the addition of fabric tape to both secure the probes and
minimise ambient light interference.
Each device was assigned a fixed side of observation
which was maintained through the experiment (CW right,
FD left) and between all participants. One probe/channel
was placed on the forehead with the probe centre point
located 4 cm from the midline and 3.5 cm above the
superior orbital ridge (targeted at cerebral tissue) (Fig. 4).
The second probe/channel of each device was placed over
and in line with the zygomatic arch, targeted specifically at
non-neurological (somatic tissue). The purpose of this
placement was to observe any overt difference between
cerebrally targeted and non-cerebrally targeted NIRS
parameters during hypoxia, and if this varied between
devices. This field of NIRS acquisition in health incorpo-
rates skin, bone (posterior zygoma) and muscle (pterigoid
and temporalis) but no air. Anatomically this region would
not normally incorporate and air cavity, and this was
confirmed on a number of participant specific archive MR
images.
An initial room air stabilisation period (ascertaining
baseline expiratory gas composition) proceeded formal
clamping of end-tidal gases to ensure participant comfort
and consistent readings. From here, an initial end-tidal
gas clamp was then applied, with end-tidal Oxygen and
Carbon Dioxide clamped at 100 and 40 mmHg respec-
tively. This was maintained for 5 min before the com-
mencement of 2 stepwise 5-min periods of hypoxia, with
isocapnia maintained. The first 5-min stage of hypoxia
reduced an individuals inspired oxygen to a partial
pressure of 60 mmHg, with the second reducing this
further to 40 mmHg. After this the baseline clamp values
were then restored and maintained for the final 5 min of
the protocol (Fig. 5). Participants were asked to relax and
rest during the procedure, and to breathe as naturally as
possible.
Participants were continuously monitored by qualified
clinical staff during the procedure, and non-verbal contact
was maintained during the procedure to maintain comfort
and safety.
3.5 Data analysis
Simultaneous data obtained from both NIRS devices
during the hypoxia protocol from each individual was
directly compared. A variety of parameters were com-
pared, including: baseline noise, baseline mean values, the
quantity of change observed during each phase of iso-
capnic hypoxia and the magnitude rebound re-saturation
observed when the hypoxia clamp was released. Data was
compared using a variety of descriptive statistics and
paired non-parametric statistical tests including Wilcoxon
signed rank test. All data analysis was carried out using in
house written code in a commercial software package
(MATLAB (R2015a) Mathworks Inc. Natick, Ma, 2000).
4 Results
4.1 Baseline variability and noise
A total of 9 healthy individuals (6 Male) completed the
isocapnic hypoxia protocol. One participant was unable to
tolerate the second stage (40 mmHg) hypoxia for the full
specified 5 min due to discomfort. The initial 100 s of this
second stage of hypoxia was maintained and stable output
parameters were observed, therefore this individual’s data
was maintained for analysis.
For practical purposes during our analysis the two stages
of hypoxia will be considered as a single step change in
J Clin Monit Comput
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observed parameters. The main reason for hypoxia being
induced in 2 stages was largely one of participant comfort.
The mean baseline parameters observed in the somati-
cally targeted probes were consistently higher than
parameters recorded by those targeted at brain tissue (77 vs
63 % CW/NIRO and 72.7 vs 61.8 % FD/ISS; P = 0.0078
and 0.0039, respectively). Consistently a greater level of
noise was observed by the FD (ISS) NIRS device
throughout the experiment (SD of baseline traces 1.37 vs
0.87 %). In terms of baseline variability, both devices
demonstrated a marked variability in baseline parameters
(Table 1).
4.2 Observed changes during hypoxic clamp
(Table 1)
The brain directed parameters (% Saturation/TOI)
observed by both devices changed markedly on moving
from the initial baseline clamp to the second stage of
induced hypoxia (i.e., 9.8 and 7 % reduction from baseline
for the CW/NIRO and FD/ISS devices, S.D 2.3 and 3.4 %
respectively) these changes were statistically significant
(Wilcoxon signed rank test P\ 0.01 for both devices).
Similar significant changes were seen in the non-neuro-
logical somatically targeted probes (P\ 0.01 for both
devices).
The changes observed during hypoxia between the
neurologically targeted probes and those targeted at the
zygomatic/somatic tissue were not significantly different in
either probe (P = 0.1289 and 0.3594 NIRO and ISS
respectively). This suggests a similar level of desaturation
during hypoxia in both tissues, although caution must be
taken in interoperating these results, this is a small sample
size and a larger investigation may yield different results.
4.3 Observed cerebral changes during release
from hypoxic clamp
After release of the hypoxic clamp a substantial increase in
cerebrally derived parameters was seen in both devices.
This was the single largest change in parameters seen
during the protocol. In both cases the changes seen by each
device (from 40 to 100 mmHg) were highly significant
(P = 0.001953 for both the NIRO and ISS), indicating
once again that both devices clearly demonstrate the ability
to detect the changes induced by the release of the hypoxia
clamp. In all cases stable post release (100 mmHg)
parameters were obtained within 40 s. A mean rise from
hypoxia of 9.7 % was detected by the NIRO (Range
4.4–13.4 % median 13.2 %), with the ISS observing a
slightly lower average change of 8.9 % (Range 4.6–13.7 %
median 9.6 %). There was no statistically significant dif-
ference between the changes detected by either device
(P = 0.625).
5 Discussion
We have demonstrated that both of the devices tested have
the ability to detect both the significant decrease in derived
NIRS tissue saturation during induced hypoxia and the
Fig. 4 NIRS position and DEF
illustrated
Fig. 5 Isocapnic hypoxia protocol
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significant increase in these seen after release of the
hypoxic clamp. Of interest was the performance of the ISS/
FD device which seemed to perform in an indistinguishable
way in its ‘as purchased’ form to the NIRO/CW device,
despite the theoretical/technical advantage of its FD
parameter recovery method. It is also noteworthy that the
output parameters produced by this device were noticeably
noisier (Fig. 6). This would potentially prove a disadvan-
tage within the clinical arena and in particular acute trau-
matic brain injury (TBI) care, where observational
conditions could be sub optimal.
The consistently lower baseline parameters observed by
the probes targeted at brain tissue (compared to those tar-
geted at somatic tissues in the facial skeleton) could be
explained physiologically by the significantly lower base-
line oxygen demands of the resting state bone, muscle and
skin tissue compared to the brain. This is an interesting
observation, highlighting the very different nature of the
tissue under the respective probes and reaffirming the
ability of both devices to detect cerebral activity. A limi-
tation of this investigation is that we have not identified the
specific degree by which the superficial tissues have
influenced these parameters in either device, and therefore
these results must be interpreted appropriately. The
incorporation of different physiological conditions
(hypocapnia), or other respiratory manoeuvres may
potentially help quantify this in future studies.
The level of noise observed in the output parameters of
the ISS/FD device was noticeably (and consistently)
greater than that seen from the NIRO/CW. This may be
explained by the highly sensitive phase measurements
made by this frequency-domain model, detecting moment-
to- moment changes in physiology and as output data are at
a modest 1 Hz this would intuitively lead to a more noisy
trace (Fig. 6). In addition the FD/ISS device utilised fibre
optic light transfer which is then amplified within the
device by a photo-multiplication device, as opposed to the
NIRO/CW device which detects light from the tissues
directly via surface photodiodes. These differences in light
detection methods may also contribute to the levels of
noise observed in output parameters.
For the purposes of clinical application, the coefficient
of variance of baseline cerebral parameters seen (8.4 and
9.7 % for the NIRO and ISS respectively) is greater than
the reduction seen in the case of 3 subjects in the case of
the NIRO, and 4 subjects in the case of the ISS. This
indicates that the baseline parameters obtained from either
device is not sufficiently consistent to be utilised for clin-
ical purposes.
The outcomes of this investigation cannot be extrapo-
lated to FD-NIRS technology in its entirety, but in this
tested ‘point of care’ configuration. Franceschini et al. [14]
reported accurate quantitative measurements in a cohort of
healthy neonates. This utilised a modified ISS/FD device
emitting an additional 4 wavelengths of light (6 vs 2) from
each source diode, increasing system redundancy and
providing clinically accurate output parameters. Due to
these examples in the established literature we are cautious
to apply our findings to FD-NIRS generally. Therefore, FD
certainly has the potential to enhance the clinical applica-
tion of NIRS, despite no clear indication of an advantage in
our findings.
The focus of this investigation was on the ‘as supplied’
unmodified form of the devices, as modification of these
devices requires specialist knowledge and is potentially not
immediately translatable to clinical care. With this in mind,
Table 1 Table of baseline means and coefficients of variance (CV) Wilcoxon rank test significance
Baseline TOI (%)
(mean ± CV)
Hypoxia TOI (%)
(mean ± CV)
Post release TOI (%)
(mean ± CV)
NIRO Forehead 63.2 ± 8.4 53.4 ± 11.9 62.7 ± 11.1
NIRO Zygoma 77.0 ± 10 68.3 ± 9.54 77.9 ± 10.2
ISS Forehead 61.8 ± 9.7 54.8 ± 7.93 62.8 ± 9.9
ISS Zygoma 72.7 ± 6.8 64.1 ± 5.26 72.4 ± 6.7
Fig. 6 Typical participant plot, illustrating FD related noise
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we found that in tested form our FD device did not
demonstrate distinguishably different abilities from the
CW NIRO 200NX.
In terms of clinical application, both devices could
potentially be utilised to observe changes in cerebral
physiology, however baseline parameters (quantitative
measurements at the commencement of observation) are
highly variable and not useful for clinical decision making.
These limitations are widely acknowledged [15–17] and
the significant variability observed in studies contempora-
neously comparing NIRS to functional MR imaging [18].
The obvious potential benefits of FD-NIRS were recog-
nised by Calderon-Arnulphiet et al. [19], when they
undertook an investigation into to abilities of a device
(similar to device employed by our investigation) to detect
ischemic changes during vascular neurosurgical proce-
dures. They reported satisfactory detection rates of ische-
mia. However, their methodology focused primarily on the
relative changes to initial baseline (although making ref-
erence to absolute chromophore quantity).
Both probes detected significant changes in parameters
during the induction of hypoxia. This combined with the
significantly higher baseline saturation seen in the somatic
facial tissue indicates that both devices are capable of reli-
ably detecting the change in specific cerebral oxygenation
induced, and either one could be used as an effective mon-
itoring tool (within the tested context). The changes we
observed were not unexpected as we anticipated a marked
change in cerebral saturation after inducing such a profound
hypoxia equivalent to what would be experienced at the
summit of the world’s tallest mountains (5000 meters).
Within the specific context of acute TBI care (particu-
larly within a pre-hospital context), decisions regarding
brain health and the need for intervention are often required
soon after patient contact. Should NIRS be utilised in the
clinical decision making process in this tested form little
could be derived from the initially extracted parameters.
Certainly a trend could be established as to the direction of
change in parameters after a period of observation; how-
ever without initial validation/calibration (with invasive
monitoring or axial imaging) this would not be useful in
immediate management. When a baseline level of function/
brain health is known (as in cardiac bypass surgery/car-
diopulmonary resuscitation) the uncertainty regarding
baseline parameters becomes less important and the change
in trends observed becomes clinically useful [20, 21]. For
any NIRS device to be employed suitably within a TBI
context it must be able to clearly distinguish grossly
abnormal parameters (such as those related to significant
hypoxia) from the expected normal observations of the
majority of individuals.
Currently, true quantitatively accurate NIRS parameters
have only been obtained within breast tissue [22], utilising
a diffuse optical tomographic (DOT) array. These tech-
niques involve large (clinically impractical) arrays of
sources and detectors and parameters are not able to be
effectively reconstructed in real time, and still fail to pro-
vide absolute quantification in the context of cerebral tissue
monitoring [23]. A significant limiting factor in all cur-
rently available (clinically viable) NIRS devices is
knowledge of spatial priors [24] (specific dimensions of
tissue layers), and incorporation of patient specific atlas
(MRI) based data may aid in the development of future
clinically viable devices that can provide a better quanti-
tative measurement of chromophore concentration within
cerebral tissue [25].
6 Conclusion
Although FD-NIRS clearly has many advantages over
continuous-wave devices, our investigation demonstrated
that the device tested performed indistinguishably from a
similar clinically available ‘as supplied to clinicians’ CW
device within the context of detecting induced hypoxia.
The variability seen in baseline parameters between indi-
viduals (in this limited investigation) by FD-NIRS is sim-
ilar to that of CW devices, and therefore does not offer any
direct advantage of CW devices in the acute assessment
setting.
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